000 01301 a2200385 4500
005 20250515051825.0
264 0 _c20070205
008 200702s 0 0 eng d
022 _a1054-3589
024 7 _a10.1016/s1054-3589(06)54005-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCosta, E
245 0 0 _aEpigenetic targets in GABAergic neurons to treat schizophrenia.
_h[electronic resource]
260 _bAdvances in pharmacology (San Diego, Calif.)
_c2006
300 _a95-117 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCerebral Cortex
_xdrug effects
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aGABA Agents
_xchemistry
650 0 4 _aHumans
650 0 4 _aMolecular Structure
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aValproic Acid
_xchemistry
650 0 4 _agamma-Aminobutyric Acid
_xmetabolism
700 1 _aDong, E
700 1 _aGrayson, D R
700 1 _aRuzicka, W B
700 1 _aSimonini, M V
700 1 _aVeldic, M
700 1 _aGuidotti, A
773 0 _tAdvances in pharmacology (San Diego, Calif.)
_gvol. 54
_gp. 95-117
856 4 0 _uhttps://doi.org/10.1016/s1054-3589(06)54005-0
_zAvailable from publisher's website
999 _c16743746
_d16743746